Primary Record
Revumenib Citrate
- In stock
- 6,778 g
- Purity
- 98.1 %
- CAS
- 2761046-45-9
Compound Identifiers & Properties
- CAS
- 2761046-45-9
- PubChem CID
- 169490859
- SMILES
- CCN(C(C)C)C(=O)C1=C(C=CC(=C1)F)OC2=CN=CN=C2N3CC4(C3)CCN(CC4)CC5CCC(CC5)NS(=O)(=O)CC.C(C(=O)O)C(CC(=O)O)(C(=O)O)O.O
- Canonical SMILES
- CCN(C(=O)c1cc(F)ccc1Oc1cncnc1N1CC2(CCN(CC3CCC(NS(=O)(=O)CC)CC3)CC2)C1)C(C)C.O.O=C(O)CC(O)(CC(=O)O)C(=O)O
Names & Synonyms
- Revumenib Citrate
- Revuforj
- Revuforj (TN)
- RefChem:879497
- YL4RYN734D
- Revumenib citrate (USAN)
- Revumenib citrate [WHO-DD]
- orb2814857
- CHEMBL6068395
- REVUMENIB CITRATE [USAN]
- EX-A4343A
- REVUMENIB MONOCITRATE MONOHYDRATE
- SNDX-5613 monocitrate monohydrate
- D12729
- 2761046-45-9
- 2-{[4-(7-{[trans-4-(ethanesulfonamido)cyclohexyl]methyl}-2,7-diazaspiro[3.5]nonan-2-yl)pyrimidin-5-yl]oxy}-N-ethyl-5-fluoro-N-(propan-2-yl)benzamide-2-hydroxypropane-1,2,3-tricarboxylic acid monohydrate
- Benzamide, N-ethyl-2-[[4-[7-[[trans-4-[(ethylsulfonyl)amino]cyclohexyl]methyl]-2,7-diazaspiro[3.5]non-2-yl]-5-pyrimidinyl]oxy]-5-fluoro-N-(1-methylethyl)-, 2-hydroxy-1,2,3-propanetricarboxylate, hydrate (1:1:1)